Literature DB >> 28952389

Effects of serum uric acid on blood-pressure lowering treatment.

Guido Grassi1.   

Abstract

If hyperuricemia is an independent risk factor in blood-pressure control, urate-lowering therapy should be used to reduce cardiovascular risk. It may also act as a prognostic marker of other abnormalities. This review presents current evidence on the relationship between hyperuricemia and hypertension.

Entities:  

Keywords:  Serum uric acid; blood hypertension; gout; urate lowering therapy

Mesh：

Substances：

Year:  2017        PMID： 28952389     DOI： 10.1080/03007995.2017.1378520

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


  3 in total

1.  Serum metabolites are associated with all-cause mortality in chronic kidney disease.

Authors:  Jiun-Ruey Hu; Josef Coresh; Lesley A Inker; Andrew S Levey; Zihe Zheng; Casey M Rebholz; Adrienne Tin; Lawrence J Appel; Jingsha Chen; Mark J Sarnak; Morgan E Grams
Journal:  Kidney Int       Date:  2018-06-02       Impact factor: 10.612

2.  Population Attributable Risk of Hyperuricemia in Hypertension Incidence in 20-74-Year-Old Population during a 10-Year Longitudinal Cohort: Yazd Healthy Heart Cohort.

Authors:  Mojtaba Mohammadhoseini; Seyedeh Mahdieh Namayandeh; Hosein Fallahzadeh; Fatemeh Majidpour; Seyed Mahmoud Sadr-Bafghi; Mohammadhosein Soltani; Leila Hadiani; Mohammadtaghi Sarebanhassanabadi; Hossein Nough; Ahmad Karimi; Maryam Askari
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

Review 3.  Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study.

Authors:  Guido Grassi; Jennifer Vanoli; Rita Facchetti; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2022-01-25       Impact factor: 5.369
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.